{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:17:23Z","timestamp":1790083043113,"version":"4.0.1"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Mutations in the nucleophosmin 1 gene (NPM1) are common and recurrent molecular abnormalities in acute myeloid leukemia (AML). NPM1 mutations are considered to be positive prognostic factors. The beneficial effect may be due to immune responses mediated by cytotoxic T cells targeting HLA-presented peptides derived from mutated NPM1 and thereby suppressing mutated NPM1-positive hematopoiesis. While the immunogenicity of these NPM1 peptides has not been demonstrated conclusively, certain HLA-types have been linked to a lower risk of NPM1-mutated AML. <\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>In a comprehensive HLA association study at two-field resolution, we compared the proportions of HLA class I alleles between NPM1-mutated (n = 477) and\/or DNMT3A-mutated (n = 216) patients with AML and a control group of healthy individuals (n = 51,890). <\/jats:p><\/jats:sec><jats:sec><jats:title>Result<\/jats:title><jats:p>We found HLA-B*40:01 and HLA-C*03:04 to be significantly underrepresented in NPM1-mutated AML compared to the control group (4.0% vs. 10.2%, p &amp;lt; 0.001, and 8.2% vs, 15.9%, p &amp;lt; 0.001, respectively). This might suggest that neoepitopes presented by these HLA alleles trigger T-cell responses. Online epitope prediction tools predict that mutated NPM1-derived peptides bind strongly to B*40:01 and C*03:04. <\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Based on these findings, further studies should confirm the presence and functionality of neoepitope-specific T cells and characterize specific T-cell receptors (TCR). Sequence information might eventually be exploited in immunotherapeutic approaches to treat AML patients with TCR-engineered T cells or bispecific TCR T\/NK cell engagers.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1571508","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T05:23:49Z","timestamp":1749533029000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Protective effects for HLA-B*40:01 and C*03:04 in NPM1-mutated AML: result of a large HLA association study"],"prefix":"10.3389","volume":"16","author":[{"given":"Elke","family":"R\u00fccker-Braun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bose","family":"Falk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Baldauf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Massalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gesine","family":"Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Altmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Sauter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ute V.","family":"Solloch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinzenz","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Egger-Heidrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desiree","family":"Kunadt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedrich","family":"St\u00f6lzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"R\u00f6llig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan M.","family":"Middeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malte","family":"von Bonin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Thiede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander H.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Bornh\u00e4user","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Schetelig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falk","family":"Heidenreich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.v188.1","article-title":"Acute myeloid leukaemia and the immune system: implications for immunotherapy","volume":"188","author":"Barrett","year":"2020","journal-title":"Br J Haematol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404699","article-title":"Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas","volume":"21","author":"Falini","year":"2007","journal-title":"Leukemia."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-07-012252","article-title":"Acute myeloid leukemia carrying cytoplasmic\/mutated nucleophosmin (NPMc+ AML): biologic and clinical features","volume":"109","author":"Falini","year":"2007","journal-title":"Blood."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-08-299990","article-title":"Acute myeloid leukemia with mutated nucleophosmin (NPM1): is it a distinct entity","volume":"117","author":"Falini","year":"2011","journal-title":"Blood"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.192104","article-title":"Pitfalls in the molecular follow up of NPM1 mutant acute myeloid leukemia","volume":"103","author":"Bacher","year":"2018","journal-title":"Haematologica."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2024.286577","article-title":"Enforcement of stem-cell dormancy by nucleophosmin mutation is a critical determinant of unrestricted self-renewal during myeloid leukemogenesis","author":"Merlo","year":"2025","journal-title":"Haematologica."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041974","article-title":"Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype","volume":"352","author":"Falini","year":"2005","journal-title":"N Engl J Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1200\/JCO.2009.25.1496","article-title":"Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a Cancer and Leukemia Group B study","volume":"28","author":"Becker","year":"2010","journal-title":"J Clin Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-11-394395","article-title":"Mutated regions of nucleophosmin 1 elicit both CD4(+) and CD8(+) T-cell responses in patients with acute myeloid leukemia","volume":"120","author":"Greiner","year":"2012","journal-title":"Blood."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)44742-9","article-title":"Structure of the gene for rat nucleolar protein B23","volume":"265","author":"Chang","year":"1990","journal-title":"J Biol Chem"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V93.2.632","article-title":"Detection of normal and chimeric nucleophosmin in human cells","volume":"93","author":"Cordell","year":"1999","journal-title":"Blood."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(89)90241-9","article-title":"Major nucleolar proteins shuttle between nucleus and cytoplasm","volume":"56","author":"Borer","year":"1989","journal-title":"Cell."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/pro.v22.5","article-title":"Nucleophosmin mutations in acute myeloid leukemia: a tale of protein unfolding and mislocalization","volume":"22","author":"Federici","year":"2013","journal-title":"Protein Sci"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.5858\/2006-130-1687-NGMIAM","article-title":"Nucleophosmin gene mutations in acute myeloid leukemia","volume":"130","author":"Chen","year":"2006","journal-title":"Arch Pathol Lab Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1097\/BS9.0000000000000042","article-title":"Preleukemic stem cells: leave it or not","volume":"2","author":"Su","year":"2020","journal-title":"Blood Sci"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.71.2208","article-title":"Genomics of acute myeloid leukemia diagnosis and pathways","volume":"35","author":"Bullinger","year":"2017","journal-title":"J Clin Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-10-461624","article-title":"Clinical impact of DNMT3A mutations in younger adult patients with acute myeloid leukemia: results of the AML Study Group (AMLSG)","volume":"121","author":"Gaidzik","year":"2013","journal-title":"Blood."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.2174\/092986710793205372","article-title":"Molecular and enzymatic profiles of mammalian DNA methyltransferases: structures and targets for drugs","volume":"17","author":"Xu","year":"2010","journal-title":"Curr Med Chem"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.06.023","article-title":"The origin and evolution of mutations in acute myeloid leukemia","volume":"150","author":"Welch","year":"2012","journal-title":"Cell."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1101\/2024.10.26.620318","article-title":"DNMT3A(R882H) is not required for disease maintenance in primary human AML, but is associated with increased leukemia stem cell frequency","author":"Kohnke","year":"2024","journal-title":"bioRxiv."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2013.11.003","article-title":"Measuring T cell receptor and T cell gene expression diversity in antigen-responsive human CD4+ T cells","author":"Eugster","year":"2013","journal-title":"J Immunol Methods"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.289488","article-title":"A single autoimmune T cell receptor recognizes more than a million different peptides","volume":"287","author":"Wooldridge","year":"2012","journal-title":"J Biol Chem"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0204290","article-title":"Association of HLA class I type with prevalence and outcome of patients with acute myeloid leukemia and mutated nucleophosmin","volume":"13","author":"Kuzelova","year":"2018","journal-title":"PloS One"},{"key":"B24","doi-asserted-by":"publisher","first-page":"101551","DOI":"10.1016\/j.beha.2024.101551","article-title":"The Collaborative Biobank (CoBi): Donor and recipient samples & data to facilitate future research on hematopoietic cell transplantation","volume":"37","author":"Spielau","year":"2024","journal-title":"Best Pract Res Clin Haematol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-08-3167","article-title":"Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML)","volume":"107","author":"Thiede","year":"2006","journal-title":"Blood."},{"key":"B26","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.bdq.2017.12.001","article-title":"An optimized targeted Next-Generation Sequencing approach for sensitive detection of single nucleotide variants","volume":"15","author":"Stasik","year":"2018","journal-title":"Biomol Detect Quantif."},{"key":"B27","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1471-2164-15-63","article-title":"Cost-efficient high-throughput HLA typing by MiSeq amplicon sequencing","volume":"15","author":"Lange","year":"2014","journal-title":"BMC Genomics"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gks438","article-title":"Immune epitope database analysis resource","volume":"40","author":"Kim","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btv639","article-title":"Gapped sequence alignment using artificial neural networks: application to the MHC class I system","volume":"32","author":"Andreatta","year":"2016","journal-title":"Bioinformatics."},{"key":"B30","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/1471-2105-6-132","article-title":"Generating quantitative models describing the sequence specificity of biological processes with the stabilized matrix method","volume":"6","author":"Peters","year":"2005","journal-title":"BMC Bioinf"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1745-7580-4-2","article-title":"Quantitative peptide binding motifs for 19 human and mouse MHC class I molecules derived using positional scanning combinatorial peptide libraries","volume":"4","author":"Sidney","year":"2008","journal-title":"Immunome Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines3020203","article-title":"Epitope prediction assays combined with validation assays strongly narrows down putative cytotoxic T lymphocyte epitopes","volume":"3","author":"Ip","year":"2015","journal-title":"Vaccines (Basel)."},{"key":"B33","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.humimm.2009.08.006","article-title":"Estimation of high-resolution HLA-A, -B, -C, -DRB1 allele and haplotype frequencies based on 8862 German stem cell donors and implications for strategic donor registry planning","volume":"70","author":"Schmidt","year":"2009","journal-title":"Hum Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01229","article-title":"Impact of the HLA immunopeptidome on survival of leukemia patients after unrelated donor transplantation","volume":"41","author":"Crivello","year":"2023","journal-title":"J Clin Oncol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2172-9-1","article-title":"HLA class I supertypes: a revised and updated classification","volume":"9","author":"Sidney","year":"2008","journal-title":"BMC Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01716","article-title":"Predicting antigen presentation-what could we learn from a million peptides","volume":"9","author":"Gfeller","year":"2018","journal-title":"Front Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404887","article-title":"Nucleophosmin leukaemic mutants contain C-terminus peptides that bind HLA class I molecules","volume":"22","author":"Liso","year":"2008","journal-title":"Leukemia."},{"key":"B38","doi-asserted-by":"crossref","DOI":"10.1172\/JCI97482","article-title":"Mutated nucleophosmin 1 as immunotherapy target in acute myeloid leukemia","volume":"129","author":"van der Lee","year":"2019","journal-title":"J Clin Invest."},{"key":"B39","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.exphem.2016.07.008","article-title":"Longitudinal analyses of leukemia-associated antigen-specific CD8(+) T cells in patients after allogeneic stem cell transplantation","volume":"44","author":"Rucker-Braun","year":"2016","journal-title":"Exp Hematol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0219547","article-title":"Acute myeloid leukemia immunopeptidome reveals HLA presentation of mutated nucleophosmin","volume":"14","author":"Narayan","year":"2019","journal-title":"PloS One"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.26617","article-title":"Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia","volume":"10","author":"Forghieri","year":"2019","journal-title":"Oncotarget."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0127637","article-title":"Altered HLA class I profile associated with type A\/D nucleophosmin mutation points to possible anti-nucleophosmin immune response in acute myeloid leukemia","volume":"10","author":"Kuzelova","year":"2015","journal-title":"PloS One"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1401689","article-title":"Uncovering the peptide-binding specificities of HLA-C: a general strategy to determine the specificity of any MHC class I molecule","volume":"193","author":"Rasmussen","year":"2014","journal-title":"J Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2073050","DOI":"10.1080\/2162402X.2022.2073050","article-title":"NPM1 and DNMT3A mutations are associated with distinct blast immunophenotype in acute myeloid leukemia","volume":"11","author":"Kuzelova","year":"2022","journal-title":"Oncoimmunology."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-024-02137-6","article-title":"Mapping AML heterogeneity - multi-cohort transcriptomic analysis identifies novel clusters and divergent ex-vivo drug responses","volume":"38","author":"Severens","year":"2024","journal-title":"Leukemia."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1903781116","article-title":"Human NK cell receptor KIR2DS4 detects a conserved bacterial epitope presented by HLA-C","volume":"116","author":"Sim","year":"2019","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1158\/2643-3230.BCD-23-0020","article-title":"Immune surveillance of acute myeloid leukemia is mediated by HLA-presented antigens on leukemia progenitor cells","volume":"4","author":"Nelde","year":"2023","journal-title":"Blood Cancer Discov"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13215390","article-title":"An HLA-A*11:01-binding neoantigen from mutated NPM1 as target for TCR gene therapy in AML","volume":"13","author":"van der Lee","year":"2021","journal-title":"Cancers (Basel)."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1571508\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T05:23:51Z","timestamp":1749533031000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1571508\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,10]]},"references-count":48,"alternative-id":["10.3389\/fimmu.2025.1571508"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1571508","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,10]]},"article-number":"1571508"}}